Eric Ostertag, CEO of Poseida, discusses the company’s platform technology, its gene therapy pipeline, and its efforts to move beyond viral vectors.

Moving Beyond Viral Vectors for Gene Therapies

<p>RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy. </p>

Business

RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy.

Share Moving Beyond Viral Vectors for Gene Therapies

Sign up to save your podcasts

Moving Beyond Viral Vectors for Gene Therapies

Moving Beyond Viral Vectors for Gene Therapies